Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT (RAFHAS)
This study is currently recruiting participants.
Study NCT00586274   Information provided by Baylor College of Medicine
First Received: December 21, 2007   Last Updated: January 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fanconi Anemia
Additional conditions recognized in this trial
Anemia
More general conditions related to this trial
Anemia, Aplastic
Anemia, Hypoplastic, Congenital
Bone Marrow Diseases
DNA Repair-Deficiency Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Metabolic Diseases
Interventions listed in this trial
CD34 selected haploidentical PBSCT
Fludarabine
T cell infusion
Campath 1h
anti-CD45
Additional drug interventions recognized in this trial
Alemtuzumab
Fludarabine monophosphate
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Baylor College of Medicine
UTSW-Dallas


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services